{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:18:46Z","timestamp":1782361126604,"version":"3.54.5"},"reference-count":46,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.012","type":"journal-article","created":{"date-parts":[[2011,12,15]],"date-time":"2011-12-15T18:18:15Z","timestamp":1323973095000},"page":"1901-1909","source":"Crossref","is-referenced-by-count":31,"title":["Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goi\u00e2nia, Brazil"],"prefix":"10.1016","volume":"30","author":[{"given":"Ana Lucia","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Minamisava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Vicente","family":"Pessoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina C.","family":"Brandileone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sueli L.A.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Pagliarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Cassio","family":"Moraes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail L.","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2011.12.012_bib0005","series-title":"Immunization, vaccines and biologicals global immunization vision and strategy","author":"World Health Organization","year":"2011"},{"issue":"12","key":"10.1016\/j.vaccine.2011.12.012_bib0010","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/00006454-200212000-00006","article-title":"Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile","volume":"21","author":"Lagos","year":"2002","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.012_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/JCM.40.1.275-277.2002","article-title":"Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, Brazil","volume":"40","author":"Reis","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"12","key":"10.1016\/j.vaccine.2011.12.012_bib0020","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.inf.0000101475.45195.b1","article-title":"Invasive pneumococcal disease in Costa Rican children: a seven year survey","volume":"22","author":"Ulloa-Gutierrez","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.012_bib0025","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/01.inf.0000208368.67448.51","article-title":"Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina","volume":"25","author":"Tregnaghi","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.012_bib0030","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CVI.00379-06","article-title":"Ten-year surveillance of pneumococcal infections in Temuco, Chile: implications for vaccination strategies","volume":"14","author":"Inostroza","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0035","unstructured":"SIREVA. Pan American Health Organization. Informe Regional de SIREVA II: Datos por pa\u00eds y por grupos de edad sobre las caracter\u00edsticas de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasores, 2006. Documentos T\u00e9cnicos, Tecnolog\u00edas Esenciales de Salud. THR\/EV. 2008\/001. Pan American Health Organization. http:\/\/www.paho.org\/44B1956F-3F7C-45D3-A366-DBA8B1D57217\/FinalDownload\/DownloadId-E8D2804067355B49A47646D29DCED750\/44B1956F-3F7C-45D3-A366-DBA8B1D57217\/spanish\/AD\/THS\/EV\/labs_Sireva_II_2006.pdf."},{"key":"10.1016\/j.vaccine.2011.12.012_bib0040","series-title":"World Health Organization acute respiratory infections in children: case management in small hospitals in developing countries, WHO\/ARI\/90.5","year":"1990"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0045","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1473-3099(06)70411-X","article-title":"Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?","volume":"6","author":"Obaro","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0050","series-title":"Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children","author":"World Health Organization","year":"2001"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0055","series-title":"Principles and Practice of Pediatric Infectious Diseases","first-page":"245","article-title":"Acute pneumonia and its complications","author":"Mani","year":"2008"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0060","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.012_bib0065","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00006454-200004000-00006","article-title":"Etiology of community-acquired pneumonia in 254 hospitalized children","volume":"19","author":"Juv\u00e9n","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.012_bib0070","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1542\/peds.113.4.701","article-title":"Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children","volume":"113","author":"Michelow","year":"2004","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.012_bib0075","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00006454-199101000-00009","article-title":"Etiology of acute lower respiratory tract infections in Gambian children: II acute lower respiratory tract infection in children ages one to nine years presenting at the hospital","volume":"10","author":"Forgie","year":"1991","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.012_bib0080","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1177\/000992287501400203","article-title":"Bacteriologic and clinical findings in acute pneumonia of childhood","volume":"14","author":"Rapkin","year":"1975","journal-title":"Clin Pediatr (Phila)"},{"issue":"8402","key":"10.1016\/j.vaccine.2011.12.012_bib0085","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(84)90764-5","article-title":"Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea","volume":"2","author":"Shann","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0090","volume":"vol. 27","author":"Clinical Laboratory Standards Institute","year":"2007"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0095","unstructured":"Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Approved standard. CLSI document M100-19. Wayne, PA, USA, CLSI; 2009."},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.012_bib0100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1128\/JCM.02243-09","article-title":"Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes","volume":"48","author":"da Gloria Carvalho","year":"2010","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.012_bib0105","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0010-4825(92)90023-G","article-title":"Simple SAS macros for the calculation of exact binomial and Poisson confidence limits","volume":"22","author":"Daly","year":"1992","journal-title":"Comput Biol Med"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0110","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE). Censo Demogr\u00e1fico 2000. http:\/\/www.ibge.gov.br\/home\/estatistica\/populacao\/censo2000\/."},{"key":"10.1016\/j.vaccine.2011.12.012_bib0115","unstructured":"Brazilian Ministry of Health, Datasus. Informa\u00e7\u00f5es de Sa\u00fade http:\/\/tabnet.datasus.gov.br\/cgi\/deftohtm.exe?pni\/cnv\/dpnibr.def, (in Portuguese)."},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.012_bib0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S1020-49892006000500007","article-title":"Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction","volume":"19","author":"Garcia","year":"2006","journal-title":"Rev Panam Salud Publica"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.012_bib0125","first-page":"97","article-title":"Invasive pneumococcal disease and consolidated pneumonia in infants: one year of surveillance in three chilean health care centers","volume":"25","author":"Abarca","year":"2008","journal-title":"Rev Chilena Infectol"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/ajcn\/70.3.309","article-title":"Potential interventions for the prevention of childhood pneumonia in developing countries: improving nutrition","volume":"70","author":"Victora","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijid.2006.05.006","article-title":"A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age","volume":"11","author":"Hortal","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"14","key":"10.1016\/j.vaccine.2011.12.012_bib0140","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMoa035060","article-title":"A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection","volume":"349","author":"Klugman","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0145","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/00006454-200003000-00003","article-title":"Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group","volume":"19","author":"Black","year":"2000","journal-title":"Pediatr Infect Dis J"},{"issue":"9465","key":"10.1016\/j.vaccine.2011.12.012_bib0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0140-6736(05)71876-6","article-title":"Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial","volume":"365","author":"Cutts","year":"2005","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.012_bib0155","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/INF.0b013e31819637af","article-title":"Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Lucero","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0160","unstructured":"COMPAS: a phase III study to demonstrate efficacy of GlaxoSmithKline Biologicals\u2019 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media: GSK1024850A \u2013 Synflorix\u2122 (10Pn): GlaxoSmithKline (GSK) Biologicals\u2019 10-valent pneumococcal vaccine. Study No:109563 (10PN-PD-DIT-028). http:\/\/download.gsk-clinicalstudyregister.com\/files\/09bc28e7-ee05-4fec-b363-f84024992979."},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.012_bib0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1473-3099(06)70466-2","article-title":"Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness","volume":"6","author":"Brundage","year":"2006","journal-title":"Lancet Infect Dis"},{"issue":"26","key":"10.1016\/j.vaccine.2011.12.012_bib0170","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1056\/NEJMc0908216","article-title":"Bacterial pathogens and death during the 1918 influenza pandemic","volume":"361","author":"Chien","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1086\/341462","article-title":"Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor","volume":"186","author":"McCullers","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.012_bib0180","doi-asserted-by":"crossref","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","article-title":"Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States","volume":"2","author":"Simonsen","year":"2011","journal-title":"MBio"},{"issue":"3","key":"10.1016\/j.vaccine.2011.12.012_bib0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4161\/hv.2894","article-title":"Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), Chile","volume":"2","author":"Lagos","year":"2006","journal-title":"Hum Vaccin"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.012_bib0190","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1590\/S0102-311X2004000200008","article-title":"Population-based surveillance of pediatric pneumonia: use of spatial analysis in an urban area of Central Brazil","volume":"20","author":"Andrade","year":"2004","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0195","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/1471-2334-11-180","article-title":"poverty: a prospective population-based study among children in Brazil","volume":"11","author":"Th\u00f6rn","year":"2011","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.012_bib0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-0691.2005.01304.x","article-title":"Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines","volume":"12","author":"Laval","year":"2006","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"10.1016\/j.vaccine.2011.12.012_bib0205","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/INF.0b013e3180616d0f","article-title":"Distribution of Streptococcus pneumoniae serotypes in nasopharyngeal carriage and in invasive pneumococcal disease in Sao Paulo, Brazil","volume":"26","author":"Berezin","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.012_bib0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1089\/mdr.1997.3.141","article-title":"Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional Systems for Vaccines in Latin America","volume":"3","author":"Brandileone","year":"1997","journal-title":"Microb Drug Resist"},{"issue":"13","key":"10.1016\/j.vaccine.2011.12.012_bib0215","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2006.09.009","article-title":"The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease","volume":"25","author":"Hausdorff","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.012_bib0220","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1590\/S1020-49892009000400004","article-title":"Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000\u20132005","volume":"25","author":"Agudelo","year":"2009","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0225","series-title":"Per capita income. Goi\u00e2nia, Brazil","author":"Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE)","year":"2005"},{"key":"10.1016\/j.vaccine.2011.12.012_bib0230","series-title":"Population Census","author":"Instituto Brasileiro de Geografia e Estatistica (IBGE)","year":"2010"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11019359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T20:36:54Z","timestamp":1561063014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11019359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":46,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11019359"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}